Author:
Nie Man,Wang Yu,Bi Xi-Wen,Xia Yi,Sun Peng,Liu Pan-Pan,Li Zhi-Ming,Jiang Wen-Qi
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference29 articles.
1. Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, Harrison CJ, Israels T, Bailey S (2012) Burkitt’s lymphoma. Lancet 379(9822):1234–44. doi: 10.1016/S0140-6736(11)61177-X
2. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B - cell lymphoma. N Engl J Med 346:235–242. doi: 10.1056/NEJMoa011795
3. Wästerlid T, Brown PN, Hagberg O, Hagberg H, Pedersen LM, D’Amore F, Jerkeman M (2013) Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group. Ann Oncol 24:1879–1886. doi: 10.1093/annonc/mdt058
4. Perkins AS, Friedberg JW (2008) Burkitt lymphoma in adults. ASH Educ Prog Book 2008(1):341–348. doi: 10.1182/asheducation-2008.1.341
5. Rodrigo JA, Hicks LK, Cheung MC, Song KW, Ezzat H, Leger CS, Boro J, Montaner JS, Harris M, Leitch HA (2012) HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era. Adv Hematol 1:91–9. doi: 10.1155/2012/735392
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献